Dược Động Học :
▧ Absorption :
Inhalation (local)-minimal; Nasal-rapid and minimal
▧ Volume of Distribution :
* 4.6 L/kg
▧ Protein binding :
Minimally (0 to 9% in vitro) bound to plasma albumin and α1-acid glycoproteins
▧ Metabolism :
Partially metabolized to at least 8 metabolites formed primarily via hydrolysis and conjugation. The main metabolites are N-isopropylnortropium methobromide, which is formed by enzymatic hydrolysis of the ester; α-phenylacrylic acid-N-isopropylnortropine-ester methobromide, which is formed by enzymatic loss of a water; and phenylacetic acid-N-isopropylnortropine-ester methobromide, which is formed by enzymatic loss of a CH3OH-group. These metabolites appear to be inactive.
▧ Route of Elimination :
Primarily eliminated renally via active secretion.
▧ Half Life :
2-4 hours after administration orally, IV or by oral inhalation (radiolabeled ipratropium bromide assay measures parent drug and its metabolites). Using a radioreceptor assay that measures only unchanged ipratropium bromide, the initial distribution-phase half-life (t1/2 α) and terminal elimination-phase half-life (t1/2 β) were 0.07 and 1.6 hours, respectively, following a single 2 mg IV dose of the drug in healthy adults.
▧ Clearance :
* 2.3 L/min (total clearance of active ingredient)